NPM-ALK is capable of transforming fibroblasts and lymphocytes in vitro and of causing lymphomas in mice.     ///    "In this study, we used an ALK fusion protein as bait in a yeast two-hybrid screen identifying NIPA (nuclear interacting partner of ALK) as a novel downstream target of NPM-ALK. "